Literature DB >> 8703852

Activated protein C and retinal vein occlusion.

B J Hunt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8703852      PMCID： PMC505425          DOI： 10.1136/bjo.80.3.194

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  9 in total

Review 1.  Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.

Authors:  B Dahlbäck
Journal:  Thromb Haemost       Date:  1995-05       Impact factor: 5.249

Review 2.  Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.

Authors:  B Dahlbäck
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

3.  Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.

Authors:  B Zöller; P J Svensson; X He; B Dahlbäck
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

4.  Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.

Authors:  H Heijboer; D P Brandjes; H R Büller; A Sturk; J W ten Cate
Journal:  N Engl J Med       Date:  1990-11-29       Impact factor: 91.245

5.  High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis.

Authors:  N J Beauchamp; M E Daly; K K Hampton; P C Cooper; F E Preston; I R Peake
Journal:  Br J Haematol       Date:  1994-09       Impact factor: 6.998

6.  Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.

Authors:  J P Vandenbroucke; T Koster; E Briët; P H Reitsma; R M Bertina; F R Rosendaal
Journal:  Lancet       Date:  1994-11-26       Impact factor: 79.321

7.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

8.  Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication.

Authors:  E S Mocarski; M Bonyhadi; S Salimi; J M McCune; H Kaneshima
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

9.  The management of thrombosis in the antiphospholipid-antibody syndrome.

Authors:  M A Khamashta; M J Cuadrado; F Mujic; N A Taub; B J Hunt; G R Hughes
Journal:  N Engl J Med       Date:  1995-04-13       Impact factor: 91.245
  9 in total
  2 in total

Review 1.  Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease.

Authors:  M Chak; G R Wallace; E M Graham; M R Stanford
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

2.  Activated protein C resistance in central retinal vein occlusion.

Authors:  G Sanborn
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.